EMA CHMP Positive Opinions

The EMA's Committee for Medicinal Products for Human Use (CHMP) issues opinions on centralized marketing authorization applications at its monthly plenary meetings. If the CHMP issues a "Positive Opinion" and recommends the authorisation of a medicinal product, a summary of the opinion is then published and is available via the EMA's search page for medicinal products. This summary contains essential information about the medicinal product, including the recommended indication and its main benefits and risks. The final, legally binding decision on whether a medicine can be marketed in the EU is then made by the European Commission.